EUCTR2008-003581-26-SE进行中（未招募）不适用
Pharmacokinetics of levodopa using duodenal levodopa/carbidopa infusion with and without oral COMT inhibitors - DuoCOMT
Dept of Neuroscience, Uppsala University0 个研究点开始时间: 2008年5月30日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Clinically diagnosed Parkinson's disease, ongoing Duodopa therapy.
- •Age 30-90 years.
- •At least 4 persons of each gender.
- •Hoehn & Yahr-stage 3-5 at worst.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Ongoing treatment with COMT-inhibitor.
- •Treatment with neuroleptics (atypical neuroleptics are OK).
- •Liver disease.
- •Hypersensitivity against Comtess or Tasmar.
研究者
相似试验
已完成
1 期
Pharmacokinetic study of levodopa coadministration of lactoferrin in healthy volunteersJPRN-UMIN000026787Ehime university8
已完成
3 期
Effects on the pharmacokinetics of L-DOPA formulation by Proton pump inhibitors in patients with Parkinson's diseaseParkinson's diseases diseaseJPRN-UMIN000022529tano National Hospital, National Hospital Organization8
进行中（未招募）
1 期
A study investigating the pharmcokintetics (how the body processes with a drug) and pharmcodynamics (what effect the drug has on the body) of the chemotherapy drug doxorubicin, when used to treat children, adolescents and young adults with newly diagnosed cancers: osteosarcoma, Ewing's family of tumours, and Hodgkin lymphoma.Ewing family of tumoursOsteosarcomaHodgkin lymphomaMedDRA version: 14.1Level: LLTClassification code 10020328Term: Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10015570Term: Ewing's tumourSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 14.1Level: LLTClassification code 10031291Term: OsteosarcomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2011-005554-62-GBAustralian Sarcoma Group (ASSG)210
已完成
不适用
Pharmacokinetics and Pharmacodynamics of Doxorubicin in Children, Adolescents and young adults with Newly Diagnosed Osteosarcoma, Ewing Family of Tumours and Hodgkin Lymphoma A Multi-Institutional Cross-Discipline Non-Therapeutic StudyOsteosarcomaEwing Family of TumoursCancer - Children's - Leukaemia & LymphomaCancer - BoneCancer - Other cancer typesHodgkin LymphomaACTRN12609000956202Australasian Sarcoma Study Group79
招募中
Unknown
Does levodopa/carbidopa, a common Parkinson's Disease drug, affect stomach emptying, blood pressure and heart rate?Postprandial hypotensionDelayed gastric emptyingOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonCardiovascular - Diseases of the vasculature and circulation including the lymphatic systemMetabolic and Endocrine - Other metabolic disordersNeurological - Parkinson's diseaseCardiovascular - Other cardiovascular diseasesParkinson's diseaseACTRN12624001010583Professor Karen Jones, The University of Adelaide20